CVRx Dismisses Chief Revenue Officer Amid Revised Outlook, Appoints Interim Sales Head
CVRX is trading near its 52-week low of $2.2 (8.1% above the low) on elevated volume (4.7× avg).
Summary
CVRx fired its Chief Revenue Officer, Robert John, effective immediately, and named Paul Verrastro as interim head of sales. The move comes just days after the company slashed its full-year revenue guidance and amid a broader leadership shakeup.
Key Events · Executive and Board Changes · CVRX
-
Chief Revenue Officer Terminated
Effective August 10, 2026, Robert John's employment as Chief Revenue Officer ended immediately, with severance pay and benefits provided under his employment agreement.
-
Interim Sales Head Appointed
Paul Verrastro, a five-year CVRx veteran and former Chief Marketing and Strategy Officer, was named Interim Head of Sales while the company searches for a permanent successor.
-
CEO Cites Commercial Execution Issues
CEO Kevin Hykes stated the leadership change was driven by a 'revised commercial outlook and need to improve commercial execution,' referencing the recent guidance cut.
-
Second Executive Departure in Two Months
This follows the June 9, 2026 resignation of CFO Jared Oasheim, signaling significant instability in CVRx's senior leadership team.
Analysis · CVRX · Industrial Applications And Services
CVRx terminated Chief Revenue Officer Robert John effective immediately, citing a revised commercial outlook and the need for better execution. The move follows a CFO resignation in June and a guidance cut just five days ago, painting a picture of deepening operational turmoil. Stepping in as interim sales head is Paul Verrastro, a five-year company veteran, while a permanent replacement is sought. The abrupt departure of a top commercial leader during a sales-force restructuring raises questions about the company's ability to stabilize its revenue trajectory.
At the time of this filing, CVRX was trading at $2.38 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $63.1M. The 52-week trading range was $2.20 to $11.30. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.